10-Q quarterly report · filed Nov 5, 2026

Ardent Health, Inc. (ARDT) Q3 2026 10-Q Quarterly Report

Short answer

Ardent Health, Inc. (ARDT) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1.6B (up 3.1% year over year) with net income of $45M.

Q3 2026 key financials · XBRL

Revenue
$1.6B
+3.1% YoY · +0.2% QoQ
Net income
$45M
+289.6% YoY · +163.4% QoQ
EPS (diluted)
$0.31
+282.4% YoY · +158.3% QoQ

Source: XBRL data from the Ardent Health, Inc. (ARDT) Q3 2026 10-Q on SEC EDGAR. USD.

Ardent Health, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $1,624.9M, up $48.1M or 3.1% YoY, driven by adjusted admissions growth of 2.9%
  • Net income attributable to Ardent $44.5M, margin 2.7% vs negative 1.5% YoY
  • Medicaid supplemental payments $156.9M vs $186.5M YoY, the primary revenue headwind
  • Cash $766.2M and available liquidity $1,009.8M at September 30, 2026
  • Operating cash flow $258.4M vs $247.1M YoY, with $115.6M capital expenditures and $24.0M share repurchases year-to-date

Risk Factors

  • No material changes to previously disclosed risk factors in the Annual Report
  • Regulatory, legal, and compliance risks remain those identified in the Annual Report
  • Operational and competitive risks remain those identified in the Annual Report
  • Liquidity, debt, currency, and concentration risks remain those identified in the Annual Report

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Ardent Health, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.